Effects of thyroid hormone on catecholamine and its metabolite concentrations in rat cardiac muscle and cerebral cortex

Thyroid

Volumn 8, Issue 4, 1998, Pages 353-358

  Mano, Toshiki ^a   Sakamoto, Hideo ^b   Fujita, Ko ^b   Makino, Masaki ^a   Kakizawa, Hiroaki ^a   Nagata, Mutsuko ^a   Kotake, Motoko ^a   Hamada, Michiko ^a   Uchimura, Keiko ^a   Hayakawa, Nobuki ^a   Hayashi, Ritsuko ^a   Nakai, Akira ^a   Itoh, Mitsuyasu ^a   Kuzuya, Hiroshi ^b   Nagasaka, Akio ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPAMINE; 3,4 DIHYDROXYMANDELIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; ADRENALIN; CATECHOLAMINE; DOPA; DOPAMINE; HOMOVANILLIC ACID; LIOTHYRONINE; METADRENALIN; NORADRENALIN; NORMETADRENALIN; THYROID HORMONE; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; EUTHYROIDISM; HEART MUSCLE; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 13144255721     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.353     Document Type: Article

References (28)

1. Campese VM, Dequattro V 1989 Functional components of the sympathetic nervous system: regulation of organ system. In: DeGroot LJ (ed) Endocrinology. 2nd edition. WB Saunders, Philadelphia, Vol 2, pp. 1746-1747.
2. Morkin E, Flink IL, Goldman S 1983 Biochemical and physiologic effects of thyroid hormone on cardiac performance. Prog Cardiovasc Dis 25:435-464.
3. Jellinek EH, Kelly RE 1960 Cerebellar syndrome in myxedema. Lancet 2:225-227.
4. Fisher M, Mateer JE, Ullrich I, Gutrecht JA 1985 Pyramidal tract deficits and polyneuropathy in hyperthyroidism. Am J Med 78:1041-1044.
5. Garcia CA, Fleming RH 1977 Reversible corticospinal tract disease due to hyperthyroidism. Arch Neurol 34:647-648.
6. Christensen NJ 1973 Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxedema. Clin Sci Mol Med 45:163-173.
7. Polikar R, Kennedy B, Ziegler M, O'Connor DT, Smith J, Nicod P 1990 Plasma norepinephrine kinetics, dopamine-β-hydroxylase, and chromogranin-A, in hypothyroid patients before and following replacement therapy. J Clin Endocrinol Metab 70:277-281.
8. Coulombe P, Dussanlt JH, Letarte J, Simard SJ 1976 Catecholamine metabolism in disease I. Epinephrine secretion rate in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 42:125-131.
9. Williams LT, Lefkowitz RL, Watanabe AM, Hathaway DR, Besch HR Jr 1977 Thyroid hormone regulation of β-adrenergic receptor number. J Biol Chem 252:2787-2789.
10. Niizoe K, Ogawa K, Satake T 1984 Long-term effects of triiodothyronine and thiouracil on myocardial β-adrenergic receptor numbers and cAMP concentration in rats. Jpn Cire J 48:508-514.
11. Ciaraldi T, Merinetti GV 1977 Thyroxine and propylthiouracil effects in vivo on alpha and beta adrenergic receptors in rat heart. Biochem Biophys Res Commun 74:984-991.
12. Ventrella SM, Klein I 1994 β-adrenergic receptor blocking drugs in the management of hyperthyroidism. Endocrinologist 4:391-399.
13. Anderson RGG, Nilsson OR, Kuo JF 1983 β-adrenoreceptor-adenosine 3′,5′-monophosphate system in human leukocytes before and after treatment for hypothyroidism. J Clin Endocrinol Metab 56:42-45.
14. Bilezikian JP, Loed JN 1983 The influence of hyperthyroidism and hypothyroidism on α-and β-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev 4:378-388.
15. McNeill JH, Muschek LD, Brody TM 1965 The effect of triiodothyronine on cyclic AMP, phospholylase, and adenyl cyclase in rat heart. Can J Physiol Pharmacol 47:913-916.
16. Klein I, Levey GS 1984 Unusual manifestations of hypothyroidism. Arch Intern Med 144:123-128.
17. Levey GS, Klein I 1990 Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88:642-646.
18. Matson WR, Langlais P, Volicer L, Gamache PH, Bird E, Mark KA 1984 N-electrode three-dimensional liquid chromatography with electrochemical detection for determination of neurotransmitters. Clin Chem 30:1477-1488.
19. Langlias PJ, McEntee WJ, Bird ED 1980 Rapid liquid chromatographic measurement of 3-methoxy-4-hydroxyphenylglycol and other monoamine metabolites in human cerebrospinal fluid. Clin Chem 26:786-788.
20. Naoi M, Maruyama W, Acworth IN, Nakahara D, Parvez H 1993 Multi-electrode detection system for determination of neurotransmitters. In: Parvez SH, Naoi M, Nagatsu T, Parvez S (eds) Methods in Neurotransmitter and Neuropeptide Research. Techniques in the Behavioral and Neural Sciences. Elsevier Science, Inc., New York, pp. 11-13.
21. Zwaveling J, Barink HD, de Jong J, Winkler Prins EA, Pfaffendorf M, van Zwieten PA 1996 Thyroid hormone modulates inotropic responses, α-adrenoceptor density and catecholamine concentrations in the rat heart. Naunyn-Schmiedebergs Arch Pharmacol 354:755-764.
22. Nagatsu T 1973 Biochemistry of Catecholamines. University of Tokyo Press, Tokyo, pp. 75-76.
23. Simpson PC 1985 Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha1-and beta1-adrenergic receptor interaction. Circ Res 56:884-894.
24. Bishopric NH, Simpson PC, Ordahl CP 1987 Induction of the skeletal alpha-actin gene in alpha1-adrenoreceptor-mediated hypertrophy of rat cardiac myocytes. J Clin Invest 80:1194-1199.
25. Long CS, Ordahl CP, Simpson PC 1989 Alpha1-adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells. J Clin Invest 83:1078-1082.
26. Skelton CL, Sonnenblick EH 1974 Heterogeneity of contractile function in cardiac hypertrophy. Circ Res 35:83-96.
27. Polikar R, Burger AG, Scherrer U, Nicod P 1993 The thyroid and the heart. Circulation 87:1435-1441.
28. Narabayashi H, Kondo T, Hayashi A 1981 L-threo-3,4 dihydroxyphenylserine treatment for akinesia and freezing of Parkinsonnism. Proc Jpn Acad 57:351-354.